Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 30.21B | 40.62B | 53.05B | 57.55B | 46.59B | 37.63B |
Gross Profit | 6.18B | 5.74B | 2.12B | 4.44B | 3.44B | 5.17B |
EBITDA | 6.42B | 7.70B | 6.29B | 5.42B | 1.04B | 4.19B |
Net Income | 33.18M | 15.00M | 482.00M | 355.00M | 2.15B | 580.00M |
Balance Sheet | ||||||
Total Assets | 75.50B | 75.47B | 82.39B | 89.50B | 64.22B | 54.75B |
Cash, Cash Equivalents and Short-Term Investments | 15.02B | 4.03B | 3.84B | 2.87B | 2.59B | 2.74B |
Total Debt | 43.71B | 39.79B | 45.52B | 50.78B | 29.08B | 23.78B |
Total Liabilities | 60.15B | 58.17B | 63.85B | 71.03B | 51.22B | 43.41B |
Stockholders Equity | 2.30B | 1.75B | 1.90B | 64.92B | 60.82B | 52.28B |
Cash Flow | ||||||
Free Cash Flow | 1.92B | 761.00M | -158.00M | -737.00M | 243.00M | 2.80B |
Operating Cash Flow | 4.16B | 3.28B | 2.13B | 1.01B | 1.69B | 4.21B |
Investing Cash Flow | -2.46B | -2.33B | 2.54B | -18.72B | -8.93B | -2.33B |
Financing Cash Flow | -1.22B | -505.00M | -4.37B | 18.07B | 7.06B | -1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | C$3.75B | 27.08 | 9.07% | 3.75% | 6.87% | 8.42% | |
71 Outperform | C$1.62B | 16.42 | 22.50% | 2.79% | 8.49% | 14.10% | |
68 Neutral | C$4.26B | 35.86 | 8.94% | ― | 57.21% | 136.79% | |
67 Neutral | C$2.02B | 26.45 | 20.92% | 1.24% | 11.48% | 38.41% | |
57 Neutral | $3.98B | 2.83 | -0.29% | 0.78% | -36.55% | -102.52% | |
57 Neutral | C$4.32B | 23.42 | 24.11% | 2.04% | 3.90% | -57.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |